Report cover image

Transcatheter Mitral Valve Implantation (TMVI) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

Publisher GlobalData
Published Mar 29, 2024
Length 84 Pages
SKU # GBDT18743639

Description

Transcatheter Mitral Valve Implantation (TMVI) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update


Summary

GlobalData's Medical Devices sector report, “Transcatheter Mitral Valve Implantation (TMVI) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Transcatheter Mitral Valve Implantation (TMVI) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Transcatheter Heart Valve is an artificial heart valve made up of natural tissue (biological material mainly derived from cow or bovine) surrounded by a flexible mesh frame known as stent (made of steel or cobalt-chromium), all placed in a long narrow tube known as a catheter. The catheter is inserted into a large blood vessel in the groin area (transfemoral) or through a small incision in chest (transapical). Once inside the heart, the valve can then be opened into its natural position by inflation of a balloon and deployed within the patient's diseased mitral valve.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Transcatheter Mitral Valve Implantation (TMVI) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transcatheter Mitral Valve Implantation (TMVI) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transcatheter Mitral Valve Implantation (TMVI) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

84 Pages
1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Transcatheter Mitral Valve Implantation (TMVI) Overview
4 Products under Development
4.1 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Stage of Development
4.2 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Territory
4.3 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Regulatory Path
4.4 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Estimated Approval Date
4.5 Transcatheter Mitral Valve Implantation (TMVI) - Ongoing Clinical Trials
5 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products under Development by Companies
5.1 Transcatheter Mitral Valve Implantation (TMVI) Companies - Pipeline Products by Stage of Development
5.2 Transcatheter Mitral Valve Implantation (TMVI) – Companies Pipeline Products by Stage of Development
6 Transcatheter Mitral Valve Implantation (TMVI) Companies and Product Overview
6.1 C Medical Technologies Inc Company Overview
6.1.1 C Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
6.2 Abbott Vascular Inc Company Overview
6.2.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
6.3 Annulon Company Overview
6.3.1 Annulon Pipeline Products & Ongoing Clinical Trials Overview
6.4 Cardiovalve Ltd Company Overview
6.4.1 Cardiovalve Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.5 Cephea Valve Technologies, Inc. Company Overview
6.5.1 Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
6.6 Colibri Heart Valve LLC Company Overview
6.6.1 Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview
6.7 Direct Flow Medical Inc (Inactive) Company Overview
6.7.1 Direct Flow Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.8 Edwards Lifesciences Corp Company Overview
6.8.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
6.9 Emory University Company Overview
6.9.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview
6.1 Foldax Inc Company Overview
6.10.1 Foldax Inc Pipeline Products & Ongoing Clinical Trials Overview
6.11 Jenscare Scientific Co Ltd Company Overview
6.11.1 Jenscare Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.12 Jiangsu Zhenyi Medical Technology Co Ltd Company Overview
6.12.1 Jiangsu Zhenyi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.13 Lepu Medical Technology (Beijing) Co Ltd Company Overview
6.13.1 Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.14 LivaNova PLC Company Overview
6.14.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
6.15 Medtronic Plc Company Overview
6.15.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
6.16 Micro Interventional Devices, Inc. Company Overview
6.16.1 Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
6.17 MicroPort CardioFlow Medtech Corp Company Overview
6.17.1 MicroPort CardioFlow Medtech Corp Pipeline Products & Ongoing Clinical Trials Overview
6.18 MicroPort Scientific Corp Company Overview
6.18.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
6.19 MitrAssist Ltd. Company Overview
6.19.1 MitrAssist Ltd. Pipeline Products & Ongoing Clinical Trials Overview
6.2 MValve Technologies Ltd. Company Overview
6.20.1 MValve Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview
6.21 Neovasc Inc Company Overview
6.21.1 Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview
6.22 NewMed Medical Co Ltd Company Overview
6.22.1 NewMed Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.23 P+F Products + Features GmbH Company Overview
6.23.1 P+F Products + Features GmbH Pipeline Products & Ongoing Clinical Trials Overview
6.24 Polares Medical SA Company Overview
6.24.1 Polares Medical SA Pipeline Products & Ongoing Clinical Trials Overview
6.25 Shanghai Shenqi Medical Technology Co Ltd Company Overview
6.25.1 Shanghai Shenqi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.26 Sino Medical Sciences Technology Inc Company Overview
6.26.1 Sino Medical Sciences Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
6.27 Symetis SA Company Overview
6.27.1 Symetis SA Pipeline Products & Ongoing Clinical Trials Overview
6.28 Tioga Medical Inc Company Overview
6.28.1 Tioga Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.29 Trinity College Dublin Company Overview
6.29.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
6.3 University College London Company Overview
6.30.1 University College London Pipeline Products & Ongoing Clinical Trials Overview
6.31 Valcare Medical Company Overview
6.31.1 Valcare Medical Pipeline Products & Ongoing Clinical Trials Overview
6.32 Venus Medtech Hangzhou Inc Company Overview
6.32.1 Venus Medtech Hangzhou Inc Pipeline Products & Ongoing Clinical Trials Overview
7 Transcatheter Mitral Valve Implantation (TMVI)- Recent Developments
7.1 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
7.2 Feb 23, 2024: Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
7.3 Feb 07, 2024: Venus Medtech-B Passing Away of an Independent Non-executive Director and Continued Suspension of Trading
7.4 Dec 15, 2023: Venus Medtech Approves Mr. Liqiao Ma as an Executive Director
7.5 Nov 02, 2023: Venus Medtech Hangzhou Announces Resignation & Appointment of Supervisor; and Director Appointment
7.6 Oct 18, 2023: Edwards Lifesciences to Host Earnings Conference Call on October 25, 2023
7.7 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
7.8 Sep 22, 2023: Venus Medtech Hangzhou Announces Appointment of Joint Chief Executive Officer
7.9 Aug 31, 2023: Venus Medtech Hangzhou Announces Interim Results for the Six Months Ended June 30, 2023
7.1 Aug 28, 2023: Edwards Lifesciences to Present at the 2023 Wells Fargo Healthcare Conference
7.11 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
7.12 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024
7.13 Aug 06, 2023: Voluntary Announcement Self-Developed TMVR System Achieved Excellent Follow-up Results in Multiple Clinical Application Cases
7.14 Jun 08, 2023: Venus Medtech Hangzhou Notice of 2022 Annual General Meeting
7.15 Jun 02, 2023: Venus Medtech Hangzhou proposes a change of auditors, adoption of the share option scheme and resignation of joint company secretary and chief financial officer
7.16 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
7.17 Apr 12, 2023: Medtronic has a layoff in California
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Stage of Development
Table 2: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Territory
Table 3: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Regulatory Path
Table 4: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Estimated Approval Date
Table 5: Transcatheter Mitral Valve Implantation (TMVI) - Ongoing Clinical Trials
Table 6: Transcatheter Mitral Valve Implantation (TMVI) Companies - Pipeline Products by Stage of Development
Table 7: Transcatheter Mitral Valve Implantation (TMVI) – Companies Pipeline Products by Stage of Development
Table 8: C Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: AltaValve Transcatheter Mitral Valve Replacement Device - Product Status
Table 10: AltaValve Transcatheter Mitral Valve Replacement Device - Product Description
Table 11: C Medical Technologies Inc - Ongoing Clinical Trials Overview
Table 12: AltaValve Transcatheter Mitral Valve Replacement Device - AltaValve Early Feasibility Study Protocol
Table 13: Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 14: Tendyne Bioprosthetic Mitral Valve Implantation System - Product Status
Table 15: Tendyne Bioprosthetic Mitral Valve Implantation System - Product Description
Table 16: Abbott Vascular Inc - Ongoing Clinical Trials Overview
Table 17: Tendyne Bioprosthetic Mitral Valve Implantation System - Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Table 18: Tendyne Bioprosthetic Mitral Valve Implantation System - Real World Study of the Tendyne Mitral Valve System to Treat Mitral Regurgitation (RESOLVE-MR) (Tendyne PMCF Study)
Table 19: Tendyne Bioprosthetic Mitral Valve Implantation System - Tendyne European Experience Registry
Table 20: Annulon Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Mitral Valve Replacement Device - Product Status(Annulon)
Table 22: Mitral Valve Replacement Device - Product Description(Annulon)
Table 23: Cardiovalve Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Cardiovalve Transfemoral Mitral Valve System - Product Status
Table 25: Cardiovalve Transfemoral Mitral Valve System - Product Description
Table 26: Cardiovalve Ltd - Ongoing Clinical Trials Overview
Table 27: Cardiovalve Transfemoral Mitral Valve System - Cardiovalve Transfemoral Mitral Valve System in Patients at High Surgical Risk with Severe Mitral Regurgitation
Table 28: Cardiovalve Transfemoral Mitral Valve System - Early Feasibility Study of the Cardiovalve System for Tricuspid Regurgitation
Table 29: Cardiovalve Transfemoral Mitral Valve System - Early Feasibility Study of the Cardiovalve Transfemoral Mitral Valve System
Table 30: Cardiovalve Transfemoral Mitral Valve System - European Feasibility Study of High Surgical Risk Patients with Severe Mitral Regurgitation Treated with the Cardiovalve Transfemoral Mitral Valve System: AHEAD Study
Table 31: Cardiovalve Transfemoral Mitral Valve System - Evaluation of a Transcatheter Mitral Valve Replacement System for the Treatment of Severe Mitral Regurgitation with High Surgical Risk: A Chinese Feasibility Study
Table 32: Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Cephea Transcatheter Mitral Valve Replacement System - Product Status
Table 34: Cephea Transcatheter Mitral Valve Replacement System - Product Description
Table 35: Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Mitral Valve - Product Status
Table 37: Mitral Valve - Product Description
Table 38: Direct Flow Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Direct Flow Medical Transcatheter Mitral Valve - Product Status
Table 40: Direct Flow Medical Transcatheter Mitral Valve - Product Description
Table 41: Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 42: CardiAQ Mitral Valve - Product Status
Table 43: CardiAQ Mitral Valve - Product Description
Table 44: EVOQUE Mitral Eos Valve Replacement Device - Product Status
Table 45: EVOQUE Mitral Eos Valve Replacement Device - Product Description
Table 46: FORTIS Mitral Transcatheter Heart Valve - Product Status
Table 47: FORTIS Mitral Transcatheter Heart Valve - Product Description
Table 48: SAPIEN M3 - Product Status
Table 49: SAPIEN M3 - Product Description
Table 50: Edwards Lifesciences Corp - Ongoing Clinical Trials Overview
Table 51: FORTIS Mitral Transcatheter Heart Valve - Early Feasibility Study of the Edwards EVOQUE Transcatheter Mitral Valve Replacement System For the Treatment of Moderate to Severe Mitral Regurgitation
Table 52: CardiAQ Mitral Valve - Early Feasibility Study of the Edwards EVOQUE Transcatheter Mitral Valve Replacement System For the Treatment of Moderate to Severe Mitral Regurgitation
Table 53: SAPIEN M3 - SAPIEN M3 System Transcatheter Mitral Valve Replacement Via Transseptal Access
Table 54: EVOQUE Mitral Eos Valve Replacement Device - Early Feasibility Study of the Edwards EVOQUE Transcatheter Mitral Valve Replacement System For the Treatment of Moderate to Severe Mitral Regurgitation
Table 55: Emory University Pipeline Products & Ongoing Clinical Trials Overview
Table 56: MitraCath - Product Status
Table 57: MitraCath - Product Description
Table 58: Foldax Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Tria Transcatheter Mitral Valve Replacement Device - Product Status
Table 60: Tria Transcatheter Mitral Valve Replacement Device - Product Description
Table 61: Jenscare Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 62: JensRelive - Product Status
Table 63: JensRelive - Product Description
Table 64: Jiangsu Zhenyi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 65: Trudelta Transcatheter Mitral Valve Replacement System - Product Status
Table 66: Trudelta Transcatheter Mitral Valve Replacement System - Product Description
Table 67: Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 68: Transcatheter Mitral Valve Replacement System - Product Status
Table 69: Transcatheter Mitral Valve Replacement System - Product Description
Table 70: LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
Table 71: Caisson TMVR System - Product Status
Table 72: Caisson TMVR System - Product Description
Table 73: LivaNova PLC - Ongoing Clinical Trials Overview
Table 74: Caisson TMVR System - Percutaneous Mitral Valve Replacement Evaluation Utilizing IDE Early Feasibility Study (PRELUDE)
Table 75: Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 76: Intrepid Transcatheter Mitral Valve Replacement - Product Status
Table 77: Intrepid Transcatheter Mitral Valve Replacement - Product Description
Table 78: Medtronic Plc - Ongoing Clinical Trials Overview
Table 79: Intrepid Transcatheter Mitral Valve Replacement - An Early Feasibility Study of Intrepid Transcatheter Mitral Valve Replacement System in Patients with Severe, Symptomatic Mitral Regurgitation
Table 80: Intrepid Transcatheter Mitral Valve Replacement - Transcatheter Mitral Valve Replacement with the Medtronic Intrepid TMVR System in Patients with Severe Symptomatic Mitral Regurgitation - APOLLO Trial
Table 81: Intrepid Transcatheter Mitral Valve Replacement - Transcatheter Mitral Valve Replacement With the Medtronic Intrepid TMVR Transfemoral System in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial
Table 82: Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 83: Endovalve - Transcatheter Mitral Valve Replacement System - Product Status
Table 84: Endovalve - Transcatheter Mitral Valve Replacement System - Product Description
Table 85: MicroPort CardioFlow Medtech Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 86: Mitral Valve Replacement Device - Product Status(MicroPort CardioFlow Medtech Corp)
Table 87: Mitral Valve Replacement Device - Product Description(MicroPort CardioFlow Medtech Corp)
Table 88: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 89: In-House Developed Replacement Product - Product Status
Table 90: In-House Developed Replacement Product - Product Description
Table 91: MitrAssist Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 92: MitrAssist Valve - Product Status
Table 93: MitrAssist Valve - Product Description
Table 94: MValve Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 95: MValve Docking System - Product Status
Table 96: MValve Docking System - Product Description
Table 97: Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 98: Tiara - TF/TS System - Product Status
Table 99: Tiara - TF/TS System - Product Description
Table 100: Tiara TA Transapical Mitral Valve - Product Status
Table 101: Tiara TA Transapical Mitral Valve - Product Description
Table 102: Neovasc Inc - Ongoing Clinical Trials Overview 5
Table 103: Tiara TA Transapical Mitral Valve - Tiara Transcatheter Mitral Valve Replacement Study (TIARA-II) 5
Table 104: NewMed Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 105: Mi-thos TMVR System - Transventricular Septal Approach - Product Status
Table 106: Mi-thos TMVR System - Transventricular Septal Approach - Product Description
Table 107: P+F Products + Features GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 108: Transcatheter Mitral Balloon-Expandable Valve - Product Status
Table 109: Transcatheter Mitral Balloon-Expandable Valve - Product Description
Table 110: Polares Medical SA Pipeline Products & Ongoing Clinical Trials Overview
Table 111: PLAR Implant and Delivery System - Product Status
Table 112: PLAR Implant and Delivery System - Product Description
Table 113: Shanghai Shenqi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 114: SQ-Kyrin Transcatheter Edge-to-Edge Valve Repair System - Product Status
Table 115: SQ-Kyrin Transcatheter Edge-to-Edge Valve Repair System - Product Description
Table 116: Shanghai Shenqi Medical Technology Co Ltd - Ongoing Clinical Trials Overview
Table 117: SQ-Kyrin Transcatheter Edge-to-Edge Valve Repair System - A Prospective, Multicenter, Single Arm Clinical Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Clip Delivery System and Steerable Guide Catheter in Patients with Moderate-severe or Severe Functional MR (FMR)
Table 118: SQ-Kyrin Transcatheter Edge-to-Edge Valve Repair System - SQ-Kyrin Transcatheter Mitral Valve Repair System Feasibility Study
Table 119: Sino Medical Sciences Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 120: AccuFit Transapical Mitral Valve Replacement Device - Product Status
Table 121: AccuFit Transapical Mitral Valve Replacement Device - Product Description
Table 122: Symetis SA Pipeline Products & Ongoing Clinical Trials Overview
Table 123: Middle Peak Mitral Implant - Product Status
Table 124: Middle Peak Mitral Implant - Product Description
Table 125: Tioga Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 126: Transcatheter Mitral Valve Replacement Device - Product Status
Table 127: Transcatheter Mitral Valve Replacement Device - Product Description
Table 128: Tioga Medical Inc - Ongoing Clinical Trials Overview
Table 129: Transcatheter Mitral Valve Replacement Device - Evaluation of Safety and Feasibility of the Tioga TMVR System for Treatment of Mitral Regurgitation
Table 130: Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 5
Table 131: Mivar Device - Product Status 5
Table 132: Mivar Device - Product Description 5
Table 133: University College London Pipeline Products & Ongoing Clinical Trials Overview 6
Table 134: Gemini Transcatheter Mitral valve - Product Status 6
Table 135: Gemini Transcatheter Mitral valve - Product Description 6
Table 136: Valcare Medical Pipeline Products & Ongoing Clinical Trials Overview
Table 137: Corona - Product Status
Table 138: Corona - Product Description
Table 139: Helios - Product Status
Table 140: Helios - Product Description
Table 141: Venus Medtech Hangzhou Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 142: Limbus - Product Status
Table 143: Limbus - Product Description
Table 144: Tresillo System - Product Status
Table 145: Tresillo System - Product Description
Table 146: Glossary
2.2 List of Figures
Figure 1: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Stage of Development
Figure 2: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Territory
Figure 3: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Regulatory Path
Figure 4: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Estimated Approval Date
Figure 5: Transcatheter Mitral Valve Implantation (TMVI) - Ongoing Clinical Trials

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us